The safety and well-being of trial participants, other patients, visitors, researchers and other clinical and support staff is paramount. As developments around the pandemic evolve, research staff are asked to note the current arrangements for new and existing research studies at RMH.

COVID-19 impact on research operations at Royal Melbourne Hospital

Advice for Clinical Trials and Other Clinical Research Studies

The Royal Melbourne Hospital (RMH) reviews and provides updated advice in relation to clinical trials and other clinical research activity.

Management of individual studies is at the discretion of, and should be coordinated by, the respective principal investigators (PIs) in consultation with their research teams and heads of department/clinical service and in accordance with current RMH advice.

For current advice researchers must refer to communication from the Office for Research which will be disseminated via email and RMH WorkPlace.

Immunisation of study participants with SAR-CoV-2 vaccine

Guidance has been developed relating to the administration of the SAR-COV-2 vaccine to study participants.


Researchers can contact the Office for Research on (03) 9342 8530 or by email to:

If the query/correspondence is related to a particular study, include the RMH project number in the information provided and subject line.

If you require a meeting, we welcome the opportunity to meet with you via online meeting platforms.

Consent for COVID-19 Research Projects

There is a template Participant Information and Consent Form (PICF) available for Coronavirus or related research that involves collection of health information and/or samples.

Please note that the template PICF wording relates to Victorian legislation.

If you are using the PICF template for a National Mutual Acceptance (NMA) project, please insert specific references for health information and samples in line with relevant state/territory legislation.

NHMRC Information

The National Health and Medical Research Council (NHMRC) has published a statement on COVID-19 impact, including information for recipients of NHMRC research grants.

The statement is available on the NHMRC website.

Contacting the Coordinating Office for Clinical Research (DHHS)

The Coordinating Office for Clinical Trial Research remains available to assist you with ethics and governance enquiries, and ERM guidance.
Research enquiries:0408 274 054
Research office information:0408 274 054
Hours:9am-5pm, Monday-Friday
Website:Coordinating Office for Clinical Trial Research

We thank you for your patience and understanding during this time, while there may be restrictions to usual work environments.